Discovery shines light on the mystery of cell death in multiple sclerosis

June 12, 2018, University of Alberta Faculty of Medicine & Dentistry
Christopher Power and Brienne McKenzie in the lab where they discovered a unique process of brain cell death that affects the cells that are most vulnerable in multiple sclerosis. Credit: Melissa Fabrizio

Researchers at the University of Alberta have discovered a unique process of brain cell death that affects the cells that are most vulnerable in multiple sclerosis (MS).

After identifying the process called pyroptosis, or fiery death, the researchers were able to block the enzyme in the that is responsible for it, using a drug that could potentially treat MS.

"This could be a game changer, because we discovered a fundamental mechanism by which are damaged in MS that couples inflammation with neurodegeneration," said Chris Power, a neurologist, lead author of the study and co-director of the UAlberta MS Centre. "The drug is already known to be safe in humans."

MS is a common disease of the brain and spinal cord that affects people in the prime of their life. There is currently no curative treatment for MS and its cause remains unknown. On average, 11 people with MS are diagnosed daily and Alberta has one of the highest rates of the disease in the world.

The publication of the study in PNAS marks the first molecular analysis of pyroptosis in the human brain. Pyroptosis is a type of that is associated with inflammation, but its role in MS was previously unknown. Importantly, Power's lab was able to show pyroptosis in both brain tissues from MS patients and in lab models of MS.

"The study's findings make a key contribution to the MS field in identifying a novel mechanism that contributes to progression in MS," said Karen Lee, vice president of research at the MS Society of Canada. "The MS Society of Canada is encouraged by the results of this study and what it means for people living with MS—hope for another avenue through which treatment options can be explored to stop MS in its tracks."

Power's lab found that the drug known as VX-765 protected oligodendrocytes, the that insulate nerves in the brain and are susceptible to damage in MS. VX-765 is currently in clinical trials for epilepsy.

"We think this drug would break the cycle of neurotoxic inflammation and thus prevent future loss of brain cell in MS," said Brienne McKenzie, first author on the study and a Ph.D. student in the U of A's Faculty of Medicine & Dentistry.

Power and his team believe identifying this mechanism also opens the doors to new indicators for monitoring disease progression of MS, which has been challenging since symptoms can vary widely between patients.

"Existing MS treatments work to reduce inflammation, but there is nothing that targets the brain cells themselves," said Avindra Nath, clinical director of the National Institute of Neurological Disorder and Stroke at the National Institutes of Health in Bethesda, MD. "This paper identifies a clinically relevant novel pathway that opens the doors to new therapeutic targets that prevent cell damage."

The study was a collaboration with a laboratory at the National Institutes of Health in Washington, DC. The MS Society of Canada and the University Hospital Foundation provided funding support for the research.

"The University Hospital Foundation is proud to be a long-time supporter of Dr. Power's groundbreaking research. Along with our generous donors, I congratulate Dr. Power on his discovery, and look forward to his future success," said Joyce Mallman Law, president of the University Hospital Foundation.

The study 'Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis' was published in PNAS on June 12, 2018.

Explore further: How the gut influences neurologic disease

More information: Brienne A. McKenzie et al, Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis, Proceedings of the National Academy of Sciences (2018). DOI: 10.1073/pnas.1722041115

Related Stories

How the gut influences neurologic disease

May 16, 2018
A study published this week in Nature sheds new light on the connection between the gut and the brain, untangling the complex interplay that allows the byproducts of microorganisms living in the gut to influence the progression ...

Stroke: Researchers shed light on the brain recovery process and new treatment strategies

May 16, 2018
Stroke is one of three leading causes of death in Canada and leads to permanent disability in about half of survivors. During an ischemic stroke, there is a blockage of blood flow which results in cell death in a specific ...

Cells that die with a bang contribute to high death rate in bloodstream infections

October 10, 2017
Cells lining blood vessels in the lungs that are exposed to bacterial toxins don't die easy, according to a new study led by researchers at the University of Illinois at Chicago College of Medicine.

Immune system 'double agent' could be new ally in cancer fight

March 16, 2018
St. Jude Children's Research Hospital scientists have discovered that an enzyme called TAK1 functions like a "double agent" in the innate immune response, serving as an unexpected regulator of inflammation and cell death. ...

Identifying the dangers of chronic stress on multiple sclerosis

February 6, 2018
New research reveals how chronic stress and tiny brain inflammations cause fatal gut failure in a multiple sclerosis mouse model.

Researchers make important link between active ingredient in saffron and multiple sclerosis

November 4, 2011
Medical researchers at the University of Alberta have discovered that an active ingredient in the Persian spice saffron may be a potential treatment for diseases involving neuroinflammation, such as multiple sclerosis.

Recommended for you

New technique helps uncover changes in ALS neurons

June 22, 2018
Northwestern Medicine scientists have discovered that some neurons affected by amyotrophic lateral sclerosis (ALS) display hypo-excitability, using a new method to measure electrical activity in cells, according to a study ...

Broken shuttle may interfere with learning in major brain disorders

June 22, 2018
Unable to carry signals based on sights and sounds to the genes that record memories, a broken shuttle protein may hinder learning in patients with intellectual disability, schizophrenia, and autism.

Watching stem cells repair spinal cord in real time

June 22, 2018
Monash University researchers have restored movement and regenerated nerves using stem cells in zebra fish where the spinal cord is severely damaged.

Scientists discover fundamental rule of brain plasticity

June 21, 2018
Our brains are famously flexible, or "plastic," because neurons can do new things by forging new or stronger connections with other neurons. But if some connections strengthen, neuroscientists have reasoned, neurons must ...

Waking up is hard to do: Prefrontal cortex implicated in consciousness

June 21, 2018
Philosophers have pondered the nature of consciousness for thousands of years. In the 21st century, the debate over how the brain gives rise to our everyday experience continues to puzzle scientists. To help, researchers ...

Researchers find mechanism behind choosing alcohol over healthy rewards

June 21, 2018
A new study links molecular changes in the brain to behaviours that are central in addiction, such as choosing a drug over alternative rewards. The researchers have developed a method in which rats learn to get an alcohol ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.